Citrobacter spp (other)
- C. amalonaticus
- C. farmeri
- Gram negative bacilli - fermenter
Clinical Significance
These organisms are found in the environment and the gastrointestinal tract of humans and animals.
They have been associated with bacteremia, urinary tract, skin/soft tissue, and bone and joint infections.
Usual Susceptibility Pattern
These organisms produce an inducible chromosomal β-lactamase (CTX-M cefotaximase) resulting in intrinsic resistance to ampicillin and cephalothin. Hyperproduction of this enzyme results in resistance to cefazolin, ceftriaxone, +/- beta-lactamase inhibitor combination drugs. Ceftazidime may still test susceptible but should be avoided.
Empiric Therapy |
---|
TMP/SMX |
or |
Ciprofloxacin |
Severe Infections: |
Meropenem |